- About AAAP
- Member Center
- Meetings and Events
- Education and Training
- Buprenorphine
Area Directors Chair: Ismene L. Petrakis, MD
Area I (CT, ME, MA, NH, RI, VT)
Director: Hilary Smith Connery, MD, PhD
Area I Announcements
Area II (NY)
Director: Michael Scimeca, MD
Area II Announcements
Area III (DC, DE, MD, NJ, PA)
Director: Jack D. Blaine, MD
Area III Announcements
Area IV (IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, WI)
Director: Jonathan E. Dunn, MD, PhD
Area IV Announcements
Area V (AL, FL, GA, KY, MS, NC, PR, SC, TN, VA, WV)
Director: Lon R. Hays, MD
Area V Announcements
Area VI (AK, CA, HI)
Director: Martin Leamon
Area VI Announcements
Area VII (AZ, CO, ID, MT, NV, NM, OR, UT, WA, WY)
Director: Elizabeth F. Howell, MD
Area VII Announcements
Area VIII (AR, LA, OK, TX)
Director: Bryon Adinoff, MD and Michael Dawes, MD
Area VIII Announcements
Area IX (Canada, International)
Director: Robert P. Milin, MD
Area IX Announcements